LOADING
Comparing Johnson & Johnson (JNJ) and Boeing Company (BA) across the Health Care and Industrials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | BA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $533.0B | $187.8B |
| P/E Ratio | 25.6 | 94.2 |
| Forward P/E | 19.1 | 909.1 |
| PEG Ratio | 2.88 | 25.72 |
| EPS | $8.64 | $2.53 |
| Revenue Growth (YoY) | 9.9% | 14.0% |
| Profit Margin | 21.8% | 2.5% |
| Return on Equity | 26.4% | 170.0% |
| Dividend Yield | 2.35% | -- |
| Beta | 0.26 | 1.21 |
| 52-Week High | $251.71 | $254.35 |
| 52-Week Low | $143.34 | $176.77 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.